Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2EXELIXIS

02 18EXELIXIS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1220

Delist Requested :

Patent Use Description : TREATMENT OF RENAL CEL...

Patent Expiration Date : 2030-01-15

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1480

Delist Requested :

Patent Use Description : TREATMENT OF ADVANCED ...

Patent Expiration Date : 2030-01-15

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 203756

Patent Use Code : U-1617

Delist Requested :

Patent Use Description : METHOD OF TREATING MED...

Patent Expiration Date : 2030-01-15

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-4156

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-15

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-3225

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-15

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-4131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-15

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-1480

Delist Requested :

Patent Use Description : TREATMENT OF ADVANCED ...

Patent Expiration Date : 2030-01-15

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-2488

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-15

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 203756

Patent Use Code : U-1617

Delist Requested :

Patent Use Description : METHOD OF TREATING MED...

Patent Expiration Date : 2030-01-15

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

CABOZANTINIB S-MALATE

US Patent Number : 11098015

Drug Substance Claim :

Drug Product Claim :

Application Number : 208692

Patent Use Code : U-4131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-15

blank